BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 32860894)

  • 1. Eicosapentaenoic and docosahexaenoic acid derived specialised pro-resolving mediators: Concentrations in humans and the effects of age, sex, disease and increased omega-3 fatty acid intake.
    Calder PC
    Biochimie; 2020 Nov; 178():105-123. PubMed ID: 32860894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.
    Serhan CN; Libreros S; Nshimiyimana R
    Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immuno-Resolving Ability of Resolvins, Protectins, and Maresins Derived from Omega-3 Fatty Acids in Metabolic Syndrome.
    Kwon Y
    Mol Nutr Food Res; 2020 Feb; 64(4):e1900824. PubMed ID: 31797565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Over-the-counter fish oil supplementation and pro-resolving and pro-inflammatory lipid mediators in rheumatoid arthritis.
    Marchand NE; Choi MY; Oakes EG; Cook NR; Stevens E; Gomelskaya N; Kotler G; Manson JE; Lasky-Su J; Mora S; Lee IM; Tatituri R; Costenbader KH
    Prostaglandins Leukot Essent Fatty Acids; 2023 Mar; 190():102542. PubMed ID: 36773395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors.
    Keelan JA; Mas E; D'Vaz N; Dunstan JA; Li S; Barden AE; Mark PJ; Waddell BJ; Prescott SL; Mori TA
    Reproduction; 2015 Feb; 149(2):171-8. PubMed ID: 25504868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of postnatal omega-3 fatty acid supplementation on offspring pro-resolving mediators of inflammation at 6 months and 5 years of age: A double blind, randomized controlled clinical trial.
    See VHL; Mas E; Prescott SL; Beilin LJ; Burrows S; Barden AE; Huang RC; Mori TA
    Prostaglandins Leukot Essent Fatty Acids; 2017 Nov; 126():126-132. PubMed ID: 29031390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The need for precision nutrition, genetic variation and resolution in Covid-19 patients.
    Simopoulos AP; Serhan CN; Bazinet RP
    Mol Aspects Med; 2021 Feb; 77():100943. PubMed ID: 33551236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of human coronary artery plaque is associated with a high ratio of (18-hydroxy-eicosapentaenoic acid + resolvin E1) to leukotriene B
    Welty FK; Schulte F; Alfaddagh A; Elajami TK; Bistrian BR; Hardt M
    FASEB J; 2021 Apr; 35(4):e21448. PubMed ID: 33749913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake.
    Poulsen RC; Gotlinger KH; Serhan CN; Kruger MC
    Am J Hematol; 2008 Jun; 83(6):437-45. PubMed ID: 18429055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation.
    Duvall MG; Levy BD
    Eur J Pharmacol; 2016 Aug; 785():144-155. PubMed ID: 26546247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation.
    Weylandt KH; Chiu CY; Gomolka B; Waechter SF; Wiedenmann B
    Prostaglandins Other Lipid Mediat; 2012 Mar; 97(3-4):73-82. PubMed ID: 22326554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prenatal n-3 fatty acid supplementation on offspring resolvins at birth and 12 years of age: a double-blind, randomised controlled clinical trial.
    See VHL; Mas E; Prescott SL; Beilin LJ; Burrows S; Barden AE; Huang RC; Mori TA
    Br J Nutr; 2017 Dec; 118(11):971-980. PubMed ID: 29173199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega-3 fatty acids and inflammatory processes: from molecules to man.
    Calder PC
    Biochem Soc Trans; 2017 Oct; 45(5):1105-1115. PubMed ID: 28900017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EPA- and DHA-derived resolvins' actions in inflammatory bowel disease.
    Schwanke RC; Marcon R; Bento AF; Calixto JB
    Eur J Pharmacol; 2016 Aug; 785():156-164. PubMed ID: 26325092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation.
    Norris PC; Skulas-Ray AC; Riley I; Richter CK; Kris-Etherton PM; Jensen GL; Serhan CN; Maddipati KR
    Sci Rep; 2018 Dec; 8(1):18050. PubMed ID: 30575798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the dietary omega-3 fatty acids impact on murine psoriasis-like skin inflammation and associated lipid dysfunction.
    Sorokin AV; Arnardottir H; Svirydava M; Ng Q; Baumer Y; Berg A; Pantoja CJ; Florida EM; Teague HL; Yang ZH; Dagur PK; Powell-Wiley TM; Yu ZX; Playford MP; Remaley AT; Mehta NN
    J Nutr Biochem; 2023 Jul; 117():109348. PubMed ID: 37044136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro-resolving mediators produced from EPA and DHA: Overview of the pathways involved and their mechanisms in metabolic syndrome and related liver diseases.
    López-Vicario C; Rius B; Alcaraz-Quiles J; García-Alonso V; Lopategi A; Titos E; Clària J
    Eur J Pharmacol; 2016 Aug; 785():133-143. PubMed ID: 25987424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered SPMs and age-associated decrease in brain DHA in
    Martinsen A; Tejera N; Vauzour D; Harden G; Dick J; Shinde S; Barden A; Mori TA; Minihane AM
    FASEB J; 2019 Sep; 33(9):10315-10326. PubMed ID: 31251078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expert consensus report on lipid mediators: Role in resolution of inflammation and muscle preservation.
    Serhan CN; Bäck M; Chiurchiù V; Hersberger M; Mittendorfer B; Calder PC; Waitzberg DL; Stoppe C; Klek S; Martindale RG;
    FASEB J; 2024 May; 38(10):e23699. PubMed ID: 38805158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid.
    Markworth JF; Kaur G; Miller EG; Larsen AE; Sinclair AJ; Maddipati KR; Cameron-Smith D
    FASEB J; 2016 Nov; 30(11):3714-3725. PubMed ID: 27461565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.